About Somnoware

Our platform

Sleep disorders are estimated to affect 50 to 70 million Americans.¹ Approximately 5.9 million US adults are diagnosed with obstructive sleep apnea (OSA), but 23.5 million still remain undiagnosed.² The annual economic cost of OSA is estimated to be up to $165 billion.² Chronic obstructive pulmonary disease (COPD) is taking a toll on the US population as well. It’s estimated that there are up to 15 million adults in the US affected by COPD³ with close to $50 billion in annual economic costs.⁴

Health care providers caring for patients with chronic conditions such as sleep apnea and COPD struggle with a collective problem—siloed data. Siloed data in disparate systems creates barriers to patient care.

Somnoware solves this problem through a web-based platform for enhanced respiratory care management. The platform orchestrates data flow between medical devices, unifies datasets within a single platform, and automates patient engagement.

With Somnoware, our customers can unify disparate devices, platforms and data, streamline diagnostic testing workflows, and easily engage with patients. More than 800 facilities use Somnoware today.